TNT
Patients with gastrointestinal cancer commonly have poor tolerability to total neoadjuvant therapy, which reduces cancer control and survival benefit of this treatment. This study will investigate the dose-response of aerobic training (AT) on total neoadjuvant therapy tolerability in patients with LARC. This will help support integration of AT into clinical cancer care.
Recruitment Sites:
New York, NY
Various New Jersey sites
Site Contact Info
medexonc@mskcc.org
646-888-8103 TNT Study
Active Recruitment Sites
Explores guided aerobic activity during gastrointestinal cancer treatment.
Enrolling
Various New Jersey Sites Memorial Sloan Kettering Regional Sites
☎ 646-888-8103
medexonc@mskcc.org 
